ABL-BCR expression in BCR-ABL-positive human leukemia cell lines
- 15 October 1999
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 23 (11) , 1055-1060
- https://doi.org/10.1016/s0145-2126(99)00131-9
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Establishment of a novel human myeloid leukaemia cell line (HNT-34) with t(3;3)(q21;q26), t(9;22)(q34;q11) and the expression of EVI1 gene, P210 and P190 BCR/ABL chimaeric transcripts from a patient with AML after MDS with 3q21q26 syndrome.British Journal of Haematology, 1997
- The function of BCR/ABL and related proto-oncogenesCurrent Opinion in Hematology, 1997
- Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction) [see comments]Blood, 1996
- The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype [editorial; comment]Blood, 1996
- Estimation of the number of mutations necessary to cause chronic myeloid leukaemia from epidemiological dataBritish Journal of Haematology, 1996
- The ABL-BCR fusion gene is expressed in chronic myeloid leukemiaBlood, 1993
- A novel leukemia cell line, MR-87, with positive Philadelphia chromosome and negative breakpoint cluster region rearrangement coexpressing myeloid and early B-cell markersBlood, 1988